On the other hand, there are several large companies with LOTS at stake if Leronlimab gets approved for even one indication. LOTS! I have no doubt they have hired every gun out there to try to dissuade investors from pitching in with CYDY. It is possible that the price action reflects the realization that the data was very good, and thus deep pockets are scared spitless!
Market Data 
Markets 
AI
